Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,652,970
-$352,175 QoQ
Shares Held
10,446
-15.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2,100
of 4,664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intrua Financial, LLC holds $17,604,029 across 11 Drug Manufacturers - General names. JNJ ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
19,859 | $4,997,318 | |
| 2 | LLY |
ELI LILLY & Co
|
2,244 | $2,691,521 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,446 | $2,652,970 | |
| 4 | AMGN |
Amgen Inc
|
5,070 | $1,835,948 | |
| 5 | PFE |
Pfizer Inc
|
65,137 | $1,568,498 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,442 | $1,120,248 | |
| 7 | GSK |
GSK plc
|
16,873 | $884,482 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,787 | $872,129 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,652,970 | 10,446 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,005,145 | 12,294 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,985,667 | 14,427 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,143,054 | 16,951 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,459,427 | 16,101 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,144,823 | 18,963 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $2,152,090 | 14,881 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $2,729,576 | 16,843 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $2,486,766 | 17,014 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $2,700,461 | 17,071 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $3,601,885 | 22,980 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $3,871,322 | 24,856 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $4,493,371 | 27,147 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $3,680,475 | 23,745 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,719,189 | 21,054 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,949,464 | 18,055 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,354,583 | 18,898 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,245,967 | 18,315 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,781,084 | 16,257 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,657,644 | 16,456 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,421,348 | 14,698 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,444,213 | 14,872 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,683,493 | 10,697 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,534,952 | 10,310 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,908,911 | 13,574 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||